Clinical trial data key to personalization of treatment decisions
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
We push the boundaries of finance to solve complex problems and fuel progress in the world through the MIT finance ecosystem – a unique global network of people, programs, research, and partnerships.
By
A $7 per metric ton carbon tax could reduce emissions by the same amount as the flagship climate policies of the Obama administration, a new study finds.
By
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).
By
Generative artificial intelligence can help designers come up with new ideas, according to a new study.
Professor Christopher Knittel and the MIT Energy Initiative's Aisling O’Grady were one of 14 teams to win a grant from the Jameel World Education Lab.
The Clean Investment Monitor database, a new collaboration between MIT CEEPR and the Rhodium Group, shows $213 billion in clean technology and infrastructure investments in the last year.
Ahead of the presidential inauguration, MIT Sloan's Professor Andrew Lo and other panelists described advances in their research and how these discoveries are being deployed to benefit the public.
Platform co-founded by a Sloanie taps the wisdom of crowds to label medical data for AI companies.